Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy

Sorafenib is used worldwide as a first-line standard systemic agent for advanced hepatocellular carcinoma (HCC) on the basis of the results of two large-scale Phase III trials. Conversely, hepatic arterial infusion chemotherapy (HAIC) is one of the most recommended treatments in Japan. Although ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeki, Issei, Yamasaki, Takahiro, Maeda, Masaki, Hisanaga, Takuro, Iwamoto, Takuya, Fujisawa, Koichi, Matsumoto, Toshihiko, Hidaka, Isao, Marumoto, Yoshio, Ishikawa, Tsuyoshi, Yamamoto, Naoki, Suehiro, Yutaka, Takami, Taro, Sakaida, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177565/
https://www.ncbi.nlm.nih.gov/pubmed/30310535
http://dx.doi.org/10.4254/wjh.v10.i9.571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177565/
https://www.ncbi.nlm.nih.gov/pubmed/30310535
http://dx.doi.org/10.4254/wjh.v10.i9.571

Ejemplares similares